Form 4: Cytokinetics Executive Receives Stock Options and Restricted Stock Units
SEC Form 4 Filing
Brett A. Pletcher, EVP, Chief Legal Officer of Cytokinetics Inc, reports the acquisition of stock options and restricted stock units as an inducement grant.
Summary
- On August 30, 2024, Brett A. Pletcher, EVP, Chief Legal Officer of Cytokinetics Inc, acquired 33,140 shares of common stock in the form of restricted stock units (RSUs).
- These RSUs vest over three years: 40% on the first anniversary, 40% on the second, and 20% on the third, contingent upon continued employment.
- Pletcher also acquired 51,039 non-qualified stock options with an exercise price of $57.08.
- 25% of these options vest on the first anniversary of the grant date, with the remaining 75% vesting monthly over the subsequent three years, also contingent upon continued employment.
- The options expire on August 30, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices, aligning management interests with shareholders.
Positives
- The inducement grant of RSUs and stock options aligns the executive's interests with the long-term performance of the company.
- The vesting schedules incentivize continued employment and contribution to Cytokinetics.
Future Outlook
The executive's compensation is tied to the future performance of the company through vesting schedules.
Industry Context
Stock options and restricted stock units are common forms of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with shareholders.
Stakeholder Impact
- Shareholders may view this as a positive as it incentivizes management to improve company performance.
- Employees may see this as a standard part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 08/30/2024 | Date of transaction: Grant of restricted stock units and stock options. |
| 09/01/2025 | First possible date for stock option exercise. |
| 08/30/2034 | Expiration date of the stock options. |
| 09/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.